Antiviral antibody responses: the two extremes of a wide spectrum (Q36405084)

14 August 2017

1 reference

title

Antiviral antibody responses: the two extremes of a wide spectrum (English)

1 reference

14 August 2017

1 reference

2

Rolf M Zinkernagel

1 reference

14 August 2017

Lars Hangartner

1

1 reference

PubMed ID

16498452

14 August 2017

Hans Hengartner

series ordinal

3

1 reference

14 August 2017

1 March 2006

1 reference

Nature Reviews Immunology

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

231-243

1 reference

14 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nri1783

14 August 2017

0 references

cites work

A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation

1 reference

THE EPIDEMIOLOGY OF LYMPHOCYTIC CHORIOMENINGITIS IN WHITE MICE.

21 January 2018

1 reference

Hepatitis B virus infection in children

21 January 2018

1 reference

Human papillomavirus life cycle: active and latent phases

21 January 2018

1 reference

The role of antibody concentration and avidity in antiviral protection.

21 January 2018

1 reference

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

21 January 2018

1 reference

Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.

21 January 2018

1 reference

Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.

21 January 2018

1 reference

A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site

21 January 2018

1 reference

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

HIV entry and its inhibition

21 January 2018

1 reference

IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells

21 January 2018

1 reference

Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid.

21 January 2018

1 reference

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

21 January 2018

1 reference

The interaction of antibody with the major surface glycoprotein of vesicular stornatitis virus II. Monoclonal antibodies to nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes

21 January 2018

1 reference

Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.

21 January 2018

1 reference

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

21 January 2018

1 reference

The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus I. Analysis of neutralizing epitopes with monoclonal antibodies

21 January 2018

1 reference

Structure of a human common cold virus and functional relationship to other picornaviruses

21 January 2018

1 reference

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

21 January 2018

1 reference

Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design

21 January 2018

1 reference

Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression

21 January 2018

1 reference

Kinetics of protective antibodies are determined by the viral surface antigen

21 January 2018

1 reference

Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies

21 January 2018

1 reference

Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system

21 January 2018

1 reference

Natural antibodies and complement link innate and acquired immunity

21 January 2018

1 reference

Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes

21 January 2018

1 reference

Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection

21 January 2018

1 reference

Dual antigen recognition by B cells

21 January 2018

1 reference

Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host

21 January 2018

1 reference

B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection

21 January 2018

1 reference

Role of IgM antibodies versus B cells in influenza virus-specific immunity

21 January 2018

1 reference

Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections

21 January 2018

1 reference

Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child

21 January 2018

1 reference

Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus

21 January 2018

1 reference

A Critical Role for Induced IgM in the Protection against West Nile Virus Infection

21 January 2018

1 reference

IgD can largely substitute for loss of IgM function in B cells.

21 January 2018

1 reference

Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro

21 January 2018

1 reference

T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses.

21 January 2018

1 reference

Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS

21 January 2018

1 reference

Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

21 January 2018

1 reference

Deliberate removal of T cell help improves virus-neutralizing antibody production.

21 January 2018

1 reference

Induction of long-lived germinal centers associated with persisting antigen after viral infection

21 January 2018

1 reference

Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes.

21 January 2018

1 reference

Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.

21 January 2018

1 reference

Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection

21 January 2018

1 reference

HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation.

21 January 2018

1 reference

Plasma cells for a lifetime?

21 January 2018

1 reference

Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals.

21 January 2018

1 reference

CD4(+) T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-gamma or IL-4.

21 January 2018

1 reference

A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers

21 January 2018

1 reference

IgG2a restriction of murine antibodies elicited by viral infections

21 January 2018

1 reference

Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus

21 January 2018

1 reference

CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability

21 January 2018

1 reference

Epitopes involved in antibody-mediated protection from Ebola virus

21 January 2018

1 reference

Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants

21 January 2018

1 reference

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

21 January 2018

1 reference

Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis

21 January 2018

1 reference

Unmutated immunoglobulin M can protect mice from death by influenza virus infection

21 January 2018

1 reference

Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization

21 January 2018

1 reference

On natural and artificial vaccinations

21 January 2018

1 reference

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

21 January 2018

1 reference

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

21 January 2018

1 reference

Antibody response to pre-S2 and hepatitis B virus induced liver damage

21 January 2018

1 reference

Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective

21 January 2018

1 reference

Antibodies, viruses and vaccines

21 January 2018

1 reference

The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus.

21 January 2018

1 reference

Somatic mutations can lead to a loss of superantigenic and polyreactive binding.

21 January 2018

1 reference

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control

21 January 2018

1 reference

Viral persistence in vivo through selection of neutralizing antibody-escape variants.

21 January 2018

1 reference

Public versus personal serotypes of a viral quasispecies.

21 January 2018

1 reference

Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence

21 January 2018

1 reference

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.

21 January 2018

1 reference

Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D

21 January 2018

1 reference

Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization

21 January 2018

1 reference

Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model.

21 January 2018

1 reference

Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs

21 January 2018

1 reference

Somatic mutation and the maturation of immune response to 2-phenyl oxazolone

21 January 2018

1 reference

Thymus dependence of viral antigens

21 January 2018

1 reference

21 January 2018

Herpes simplex viruses

1 reference

Functional role of type I and type II interferons in antiviral defense

31 March 2020

1 reference

Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity

31 March 2020

1 reference

Class I and class II viral fusion protein structures reveal similar principles in membrane fusion

31 March 2020

1 reference

Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells

31 March 2020

1 reference

HIV-1 antibody--debris or virion?

31 March 2020

1 reference

A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity

31 March 2020

1 reference

Neutralization activity and persistence of antibodies induced in response to vaccination with a novel mumps strain, RIT 4385

31 March 2020

1 reference

Development of the antibody response in acute HIV-1 infection.

31 March 2020

1 reference

Molecular determinants of immunogenicity: the immunon model of immune response

31 March 2020

1 reference

The repertoire of serum IgM in normal mice is largely independent of external antigenic contact

31 March 2020

1 reference

Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual

31 March 2020

1 reference

Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design

31 March 2020

1 reference

Control of early viral and bacterial distribution and disease by natural antibodies

31 March 2020

1 reference

Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection

31 March 2020

1 reference

Marginal zone macrophages and immune responses against viruses

31 March 2020

1 reference

Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory

31 March 2020

1 reference

T-cell-independent antiviral antibody responses

31 March 2020

1 reference

Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid

31 March 2020

1 reference

Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections

31 March 2020

1 reference

Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure

31 March 2020

1 reference

An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus

31 March 2020

1 reference

Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase

31 March 2020

1 reference

The half-lives of serum immunoglobulins in adult mice.

31 March 2020

1 reference

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

31 March 2020

1 reference

Reinfection of mice with respiratory syncytial virus

31 March 2020

1 reference

Immunological memory and protective immunity: understanding their relation

31 March 2020

1 reference

Immunologic correlates of protection induced by vaccination

31 March 2020

1 reference

Immunology of hepatitis B infection

31 March 2020

1 reference

Accumulation of somatic mutants in the B cell compartment after primary immunization with a T cell-dependent antigen

31 March 2020

1 reference

Disquisitions of Original Antigenic Sin. I. Evidence in man

31 March 2020

1 reference

Ebola virus can be effectively neutralized by antibody produced in natural human infection

31 March 2020

1 reference

7 January 2021

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

7 January 2021

Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression.

1 reference

7 January 2021

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice

1 reference

7 January 2021

Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice

1 reference

7 January 2021

Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1038/NRI1783

Identifiers

DOI

10.1038/NRI1783

1 reference

PubMed ID

16498452

Dimensions Publication ID

14 August 2017

0 references

1 reference

PubMed ID

16498452